Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cancer surveillance in ulcerative colitis.

F W Nugent1, R C Haggitt, P A Gilpin

  • 1Department of Gastroenterology, Lahey Clinic Medical Center, Burlington, Massachusetts.

Gastroenterology
|May 1, 1991
PubMed
Summary

A biopsy surveillance program effectively manages cancer risk in ulcerative colitis patients. Patients with negative biopsy results have a low short-term cancer risk, allowing for deferred colectomy and colon preservation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mechanisms of clinical resistance to selective FGFR2 inhibition by lirafugratinib.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author

Adjuvant and neoadjuvant therapy in curable pancreatic cancer.

The Surgical clinics of North America·2010
Same author

Familial fibrocystic pancreatic atrophy with endocrine cell hyperplasia and pancreatic carcinoma.

The American journal of surgical pathology·2001
Same author

Neoplasms of the ampulla of vater with concurrent pancreatic intraductal neoplasia: a histological and molecular study.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2001
Same author

Recommendations for the reporting of resected esophageal carcinomas. Association of Directors of Anatomic Surgical Pathology.

Human pathology·2001
Same author

Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis.

Annals of internal medicine·2001

Area of Science:

  • Gastroenterology
  • Oncology
  • Colorectal Surgery

Background:

  • Ulcerative colitis (UC) patients face an increased risk of colorectal cancer.
  • Regular surveillance for dysplasia and carcinoma is crucial for managing this risk.
  • Identifying low-risk patients can help avoid unnecessary colectomies.

Purpose of the Study:

  • To evaluate the efficacy of a biopsy surveillance program in reducing cancer risk for UC patients.
  • To identify patients at low risk for carcinoma, potentially allowing them to retain their colon.
  • To assess the resource expenditure of such a surveillance program.

Main Methods:

  • A 13-year prospective study involving 213 ulcerative colitis patients without current evidence of cancer.
  • Biopsy surveillance for dysplasia and carcinoma.
  • Colectomy decisions based on biopsy findings.

Main Results:

  • Eighteen patients had initial dysplasia; 7 were diagnosed with unsuspected carcinoma (Dukes' A-C) after colectomy.
  • Eleven patients developed dysplasia during follow-up; 1 had carcinoma (Dukes' B) after colectomy.
  • No carcinoma developed in 148 patients with consistently negative biopsy results; 4 deaths from carcinoma occurred in patients with high-grade initial dysplasia.

Conclusions:

  • Biopsy surveillance is effective in controlling cancer risk in long-standing ulcerative colitis.
  • Patients with negative biopsy results have a low short-term cancer risk, and colectomy can be deferred.
  • Patients with extensive and left-sided UC share similar risks for dysplasia development.

Related Experiment Videos